Your browser doesn't support javascript.
loading
Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China.
Liu, Yuhong; Lin, Yan; Sun, Yuxian; Thekkur, Pruthu; Cheng, Changhao; Li, Yuecui; Shi, Yunzhen; Jiang, Jun; Liao, Jiong; Nie, Chuangui; Sun, Wenyan; Liang, Chengyuan; Zhang, Xiaojuan; Liu, Sang; Ma, Yan; Berger, Selma Dar; Satyanarayana, Srinath; Kumar, Ajay M V; Khogali, Mohammed; Zachariah, Rony; Golub, Jonathan E; Li, Liang; Harries, Anthony D.
Afiliação
  • Liu Y; Beijing Chest Hospital, Capital Medical University, No. 9 Beiguan Ave, Tongzhou, Beijing 101149, China.
  • Lin Y; Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
  • Sun Y; International Union Against Tuberculosis and Lung Disease, 2 Rue Jean Lantier, 75001 Paris, France.
  • Thekkur P; Beijing Chest Hospital, Capital Medical University, No. 9 Beiguan Ave, Tongzhou, Beijing 101149, China.
  • Cheng C; Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
  • Li Y; International Union Against Tuberculosis and Lung Disease, 2 Rue Jean Lantier, 75001 Paris, France.
  • Shi Y; The Union South-East Asia Office, C-6 Qutub Institutional Area, New Delhi 110016, India.
  • Jiang J; Wuhan Pulmonary Hospital, No. 28 Baofengyilu, Qiaokou, Wuhan 430000, China.
  • Liao J; The First People's Hospital of Yongkang, No. 599 Jinshan West Road, Yongkang 321300, China.
  • Nie C; Dongyang People's Hospital, No. 60 Wuning West Road, Dongyang 322100, China.
  • Sun W; The Third People's Hospital of Yichang City, No. 32 Gangyaolu, Yichang 443000, China.
  • Liang C; The People's Hospital of Laiban, No. 159 Pangudadao, Laiban 546100, China.
  • Zhang X; Xiangyang Institute of Tuberculosis Control and Prevention, No. 20 Xinhuala, Xiangyang 441000, China.
  • Liu S; Ezhou Third Hospital, No. 16 Minxin West Road, Ezhou 436000, China.
  • Ma Y; Baise City People's Hospital, No. 8 Chengxianglu, Youjiang, Baise 533000, China.
  • Berger SD; Zhongwei People's Hospital, Gulouxijie, Zhongwei 755000, China.
  • Satyanarayana S; Guangxi Chest Hospital, No. 8 Yangjiaoshanlu, Yufeng, Liuzhou 545000, China.
  • Kumar AMV; The People's Hospital of Tongxin, Xueyuanlu, Tongxi, Yuhaizhen 751100, China.
  • Khogali M; International Union Against Tuberculosis and Lung Disease, 2 Rue Jean Lantier, 75001 Paris, France.
  • Zachariah R; International Union Against Tuberculosis and Lung Disease, 2 Rue Jean Lantier, 75001 Paris, France.
  • Golub JE; The Union South-East Asia Office, C-6 Qutub Institutional Area, New Delhi 110016, India.
  • Li L; International Union Against Tuberculosis and Lung Disease, 2 Rue Jean Lantier, 75001 Paris, France.
  • Harries AD; The Union South-East Asia Office, C-6 Qutub Institutional Area, New Delhi 110016, India.
Trop Med Infect Dis ; 8(7)2023 Jun 26.
Article em En | MEDLINE | ID: mdl-37505637
ABSTRACT
Many patients with tuberculosis (TB) have comorbidities, risk determinants and disability that co-exist at diagnosis, during and after TB treatment. We conducted an observational cohort study in 11 health facilities in China to assess under routine program conditions (i) the burden of these problems at the start and end of TB treatment and (ii) whether referral mechanisms for further care were functional. There were 603 patients registered with drug-susceptible TB who started TB treatment 84% were symptomatic, 14% had diabetes, 14% had high blood pressure, 19% smoked cigarettes, 10% drank excess alcohol and in 45% the 6 min walking test (6MWT) was abnormal. Five patients were identified with mental health disorders. There were 586 (97%) patients who successfully completed TB treatment six months later. Of these, 18% were still symptomatic, 12% had diabetes (the remainder with diabetes failed to complete treatment), 5% had high blood pressure, 5% smoked cigarettes, 1% drank excess alcohol and 25% had an abnormal 6MWT. Referral mechanisms for the care of comorbidities and determinants worked well except for mental health and pulmonary rehabilitation for disability. There is need for more programmatic-related studies in other countries to build the evidence base for care of TB-related conditions and disability.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article